glucosamine/chondroitin sales have fallen 3.5%
Vioxx/Bextra off the market 26.9 million prescriptions left empty
December 25, 2006 (Press Release) --
Safety issues relating to a class of prescription drugs were brought into doubt, when chemists started pulling Vioxx off their shelves.
Pfizer likewise pulled their product Bextra from the market a short time later, after the Food and Drug Administration made the recommendation to do so.
26.9 million Prescriptions were written for those two medicines alone.
Consumers are remaining loyal to the cox-2 inhibitor are driving up sales of Pfizer's Celebrex. Over the counter pain relievers, especially those which target arthritic pain have been reaching double digit increment growth.
However glucosamine/chondroitin sales have fallen 3.5%, it is predicted this is happening because most patients using Bextra already tried glucosamine before their use of Bextra.
The problems with glucosamine are that results tend to take 4-6 weeks consumers are demanding more instant help for their pain.
Pharmavite a natural medicine manufacturer plans to step up their advertising of CholestOff and TripleFlex using direct market television and tempting viewers to call their toll free number, or visit their website for a $5.00 off coupon.
In 2003 PatentHealth launched a microlactin product called FluidJoint.
Mircolactin is an ingredient which reduces neutrophils in the sore joint, reducing pain and inflammation. Clinical trials suggest that pain is reduced in just two weeks. It is not an instant cure; then again it does not carry the side effects of those products that do offer an instant cure.
Lubriflex3 from Welder, also a newly launched product targets joint and bone health with the use of ingredients such as glucosamine, hyaluronic acid and a proprietary blend of antioxidants called Uniflex. Lubriflex3 is claimed to be a fast acting supplement.
Natural medicines seem like a good alternative for arthritis sufferers, but few are willing to try them, instead many have chosen to suffer with arthritic pain.
For further information please see http://www.bextralawyerguide.info
Pfizer likewise pulled their product Bextra from the market a short time later, after the Food and Drug Administration made the recommendation to do so.
26.9 million Prescriptions were written for those two medicines alone.
Consumers are remaining loyal to the cox-2 inhibitor are driving up sales of Pfizer's Celebrex. Over the counter pain relievers, especially those which target arthritic pain have been reaching double digit increment growth.
However glucosamine/chondroitin sales have fallen 3.5%, it is predicted this is happening because most patients using Bextra already tried glucosamine before their use of Bextra.
The problems with glucosamine are that results tend to take 4-6 weeks consumers are demanding more instant help for their pain.
Pharmavite a natural medicine manufacturer plans to step up their advertising of CholestOff and TripleFlex using direct market television and tempting viewers to call their toll free number, or visit their website for a $5.00 off coupon.
In 2003 PatentHealth launched a microlactin product called FluidJoint.
Mircolactin is an ingredient which reduces neutrophils in the sore joint, reducing pain and inflammation. Clinical trials suggest that pain is reduced in just two weeks. It is not an instant cure; then again it does not carry the side effects of those products that do offer an instant cure.
Lubriflex3 from Welder, also a newly launched product targets joint and bone health with the use of ingredients such as glucosamine, hyaluronic acid and a proprietary blend of antioxidants called Uniflex. Lubriflex3 is claimed to be a fast acting supplement.
Natural medicines seem like a good alternative for arthritis sufferers, but few are willing to try them, instead many have chosen to suffer with arthritic pain.
For further information please see http://www.bextralawyerguide.info
Email
Print
Download
SPAM
LEAVE A COMMENT
